Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Editorial

Targeting tumor hypoxia and hypoxia-inducible factors (HIFs) for the treatment of cancer- A story of transcription factors with novel approach in molecular medicine

Author(s): Sukhes Mukherjee and Suman Kumar Ray

Volume 22, Issue 4, 2022

Published on: 25 March, 2022

Page: [285 - 286] Pages: 2

DOI: 10.2174/156652402204220325161921

conference banner
Next »
[1]
Ray SK, Mukherjee S. Current Headway in Cancer Immunotherapy Emphasizing the Practice of Genetically Engineered T Cells to Target Selected Tumor Antigens. Crit Rev Immunol 2021; 41(1): 23-40.
[2]
Petrova V, Annicchiarico-Petruzzelli M, Melino G, et al. The hypoxic tumour microenvironment. Oncogenesis 2018; 7: 10.
[3]
Ivanova IG, Park CV, Kenneth NS. Translating the Hypoxic Response—The Role of HIF Protein Translation in the Cellular Response to Low Oxygen. Cells 2019; 8(2): 114.
[4]
Strowitzki MJ, Cummins EP, Taylor CT. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous? Cells 2019; 8(5): 384.
[5]
Gilkes DM, Semenza GL. Role of hypoxia-inducible factors in breast cancer metastasis. Future Oncol 2013; 9(11): 1623-36.
[6]
Jin X, Dai L, Ma Y, Wang J, Liu Z. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int 2020; 20: 273.
[7]
Zhou Z, Liu F, Zhang ZS, et al. Human rhomboid family-1 suppresses oxygen-independent degradation of hypoxia-inducible factor-1α in breast cancer. Cancer Res 2014; 74(10): 2719-30.
[8]
Emami Nejad A, Najafgholian S, Rostami A, et al. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 2021; 21(1): 62.
[9]
Tam SY, Wu VWC, Law HKW. Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond. Front Oncol 2020; 10: 486.
[10]
Zhang Y, Zhang H, Wang M, et al. Hypoxia in Breast Cancer-Scientific Translation to Therapeutic and Diagnostic Clinical Applications. Front Oncol 2021; 11652266
[11]
Ray SK, Mukherjee S. Cell free DNA as an evolving liquid biopsy biomarker for initial diagnosis and therapeutic nursing in Cancer- An evolving aspect in Medical Biotechnology. Curr Pharm Biotechnol 2020 Dec 10.
[http://dx.doi.org/10.2174/1389201021666201211102710] [PMID: 33308128]
[12]
Ray SK, Mukherjee S. LncRNAs as an Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy. Curr Cancer Drug Targets 2021 Jan 6.
[http://dx.doi.org/10.2174/1568009620666210106122421] [PMID: 33413062]

© 2024 Bentham Science Publishers | Privacy Policy